Normative Data on Serum and Plasma Tryptophan and Kynurenine Concentrations from 8089 Individuals Across 120 Studies: A Systematic Review and Meta-Analysis.

IF 2.7 Q3 NEUROSCIENCES
International Journal of Tryptophan Research Pub Date : 2023-11-29 eCollection Date: 2023-01-01 DOI:10.1177/11786469231211184
Najwa-Joelle Metri, Ali S Butt, Ava Murali, Genevieve Z Steiner-Lim, Chai K Lim
{"title":"Normative Data on Serum and Plasma Tryptophan and Kynurenine Concentrations from 8089 Individuals Across 120 Studies: A Systematic Review and Meta-Analysis.","authors":"Najwa-Joelle Metri, Ali S Butt, Ava Murali, Genevieve Z Steiner-Lim, Chai K Lim","doi":"10.1177/11786469231211184","DOIUrl":null,"url":null,"abstract":"<p><p>In this systematic review and meta-analysis, a normative dataset is generated from the published literature on the kynurenine pathway in control participants extracted from case-control and methodological validation studies. Study characteristics were mapped, and studies were evaluated in terms of analytical rigour and methodological validation. Meta-analyses of variance between types of instruments, sample matrices and metabolites were conducted. Regression analyses were applied to determine the relationship between metabolite, sample matrix, biological sex, participant age and study age. The grand mean concentrations of tryptophan in the serum and plasma were 60.52 ± 15.38 μM and 51.45 ± 10.47 μM, respectively. The grand mean concentrations of kynurenine in the serum and plasma were 1.96 ± 0.51 μM and 1.82 ± 0.54 μM, respectively. Regional differences in metabolite concentrations were observed across America, Asia, Australia, Europe and the Middle East. Of the total variance within the data, mode of detection (MOD) accounted for up to 2.96%, sample matrix up to 3.23%, and their interaction explained up to 1.53%; the latter of which was determined to be negligible. This review was intended to inform future empirical research and method development studies and successfully synthesised pilot data. The pilot data reported in this study will inform future precision medicine initiatives aimed at targeting the kynurenine pathway by improving the availability and quality of normative data.</p>","PeriodicalId":46603,"journal":{"name":"International Journal of Tryptophan Research","volume":"16 ","pages":"11786469231211184"},"PeriodicalIF":2.7000,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687991/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Tryptophan Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11786469231211184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

In this systematic review and meta-analysis, a normative dataset is generated from the published literature on the kynurenine pathway in control participants extracted from case-control and methodological validation studies. Study characteristics were mapped, and studies were evaluated in terms of analytical rigour and methodological validation. Meta-analyses of variance between types of instruments, sample matrices and metabolites were conducted. Regression analyses were applied to determine the relationship between metabolite, sample matrix, biological sex, participant age and study age. The grand mean concentrations of tryptophan in the serum and plasma were 60.52 ± 15.38 μM and 51.45 ± 10.47 μM, respectively. The grand mean concentrations of kynurenine in the serum and plasma were 1.96 ± 0.51 μM and 1.82 ± 0.54 μM, respectively. Regional differences in metabolite concentrations were observed across America, Asia, Australia, Europe and the Middle East. Of the total variance within the data, mode of detection (MOD) accounted for up to 2.96%, sample matrix up to 3.23%, and their interaction explained up to 1.53%; the latter of which was determined to be negligible. This review was intended to inform future empirical research and method development studies and successfully synthesised pilot data. The pilot data reported in this study will inform future precision medicine initiatives aimed at targeting the kynurenine pathway by improving the availability and quality of normative data.

120项研究中8089名个体血清和血浆色氨酸和犬尿氨酸浓度的规范数据:系统回顾和荟萃分析
在这项系统回顾和荟萃分析中,从病例对照和方法学验证研究中提取的对照参与者的犬尿氨酸途径的已发表文献中生成了一个规范的数据集。绘制研究特征,并根据分析严谨性和方法有效性对研究进行评估。对仪器类型、样品基质和代谢物之间的差异进行meta分析。采用回归分析确定代谢物、样品基质、生物学性别、参与者年龄和研究年龄之间的关系。血清和血浆色氨酸的大平均浓度分别为60.52±15.38 μM和51.45±10.47 μM。血清和血浆中犬尿氨酸的大平均浓度分别为1.96±0.51 μM和1.82±0.54 μM。在美洲、亚洲、澳大利亚、欧洲和中东观察到代谢物浓度的区域差异。在数据内的总方差中,检测模式(mode Of detection, MOD)占比高达2.96%,样本矩阵占比高达3.23%,它们的相互作用解释率高达1.53%;后者被认为是微不足道的。该综述旨在为未来的实证研究和方法开发研究提供信息,并成功地合成了试点数据。本研究中报告的试点数据将通过提高规范性数据的可用性和质量,为未来针对犬尿氨酸途径的精准医学举措提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.30
自引率
4.50%
发文量
19
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信